Leadership Team

The Leadership Team at Dilafor AB is responsible for defining the strategic direction of the company and overseeing the development of tafoxiparin for obstetric indications. This team collaborates on critical decisions related to drug development, operational efficiency, and regulatory compliance, while also ensuring alignment with the company's mission to improve maternal health outcomes. With a focus on innovation and patient safety, they guide the organization toward successful clinical trials and market entry.